Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial
Elias Dakwar, Edward V. Nunes, Carl L. Hart, et al.
American Journal of Psychiatry (2019) Vol. 176, Iss. 11, pp. 923-930
Open Access | Times Cited: 125

Showing 26-50 of 125 citing articles:

Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100025-100025
Open Access | Times Cited: 33
Cocaine Use Disorder (CUD): Current Clinical Perspectives
Elizabeth Schwartz, Noah R. Wolkowicz, João P. De Aquino, et al.
Substance Abuse and Rehabilitation (2022) Vol. Volume 13, pp. 25-46
Open Access | Times Cited: 32
Toward Synergies of Ketamine and Psychotherapy
David S. Mathai, Victoria Mora, Albert Garcia‐Romeu
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 31
Active mechanisms of ketamine-assisted psychotherapy: A systematic review
Isak Joneborg, Yena Lee, Joshua D. Di Vincenzo, et al.
Journal of Affective Disorders (2022) Vol. 315, pp. 105-112
Closed Access | Times Cited: 29
Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study
Grant Jones, Matthew K. Nock
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, et al.
Psychopharmacology (2023) Vol. 240, Iss. 7, pp. 1547-1560
Open Access | Times Cited: 18
Mindfulness in Treatment Approaches for Addiction — Underlying Mechanisms and Future Directions
Annika Rosenthal, Michael E. Levin, Eric L. Garland, et al.
Current Addiction Reports (2021) Vol. 8, Iss. 2, pp. 282-297
Open Access | Times Cited: 37
Therapeutic potential of ketamine for alcohol use disorder
Stephen Worrell, Thomas J. Gould
Neuroscience & Biobehavioral Reviews (2021) Vol. 126, pp. 573-589
Closed Access | Times Cited: 35
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing
Jennifer Swainson, Larry J. Klassen, Stefan Brennan, et al.
CNS Drugs (2022) Vol. 36, Iss. 3, pp. 239-251
Open Access | Times Cited: 25
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.
Nicolas Garel, Christina McAnulty, Kyle T. Greenway, et al.
Drug and Alcohol Dependence (2022) Vol. 239, pp. 109606-109606
Open Access | Times Cited: 25
Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report
Matthew Hicks, Heather Zwickey, Ryan Bradley
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review
Theodore Piper, Francesca Small, Sam P. Brown, et al.
Addiction (2025)
Open Access
Impact of psychedelics on craving in addiction: A systematic review
Sophie‐Athéna Chapron, Guilhem Bonazzi, Laura Di Lodovico, et al.
Journal of Psychopharmacology (2025)
Closed Access
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)
Kathryn Fletcher, Nadine Ezard, Krista J. Siefried, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092504-e092504
Open Access
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization
Jennifer Jones
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy
Maria Eleni Eleftheriou, Emily M Thomas
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 32
The Effectiveness of Cognitive Behavioral Therapy Techniques for the Treatment of Substance Use Disorders
Lorenzo Zamboni, Francesco Centoni, Francesca Fusina, et al.
The Journal of Nervous and Mental Disease (2021) Vol. 209, Iss. 11, pp. 835-845
Closed Access | Times Cited: 27
Acute Dissociation and Ketamine’s Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial
Sumra Sajid, Hanga Galfalvy, John G. Keilp, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 4
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review
Vivian W. L. Tsang, Brendan Tao, Shannon Dames, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 9
Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study
Antoine Elyn, Anne Roussin, C. Lestrade, et al.
Regional Anesthesia & Pain Medicine (2024), pp. rapm-105035
Closed Access | Times Cited: 3
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine
Viviana D. Evans, Alejandro Arenas, Kenneth Shinozuka, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e155-e177
Closed Access | Times Cited: 3
Strategies to Improve Patient-Centered Care for Drug Use-Associated Infective Endocarditis
Alysse G. Wurcel, Joji Suzuki, Asher J Schranz, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 14, pp. 1338-1347
Closed Access | Times Cited: 3
The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS)
Angela T.H. Kwan, Joshua D. Rosenblat, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 360, pp. 421-426
Closed Access | Times Cited: 3
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
E.M. Van Gent, J. Bryan, M Cleary, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 6, pp. 541-550
Open Access | Times Cited: 3
Psychedelics: From Cave Art to 21st-Century Medicine for Addiction
Ioanna A. Vamvakopoulou, David Nutt
European Addiction Research (2024), pp. 1-19
Open Access | Times Cited: 3

Scroll to top